Download e-book Antiplatelet and Anticoagulation Therapy (Current Cardiovascular Therapy)

Free download. Book file PDF easily for everyone and every device. You can download and read online Antiplatelet and Anticoagulation Therapy (Current Cardiovascular Therapy) file PDF Book only if you are registered here. And also you can download or read online all Book PDF file that related with Antiplatelet and Anticoagulation Therapy (Current Cardiovascular Therapy) book. Happy reading Antiplatelet and Anticoagulation Therapy (Current Cardiovascular Therapy) Bookeveryone. Download file Free Book PDF Antiplatelet and Anticoagulation Therapy (Current Cardiovascular Therapy) at Complete PDF Library. This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats. Here is The CompletePDF Book Library. It's free to register here to get Book file PDF Antiplatelet and Anticoagulation Therapy (Current Cardiovascular Therapy) Pocket Guide.

Update on the duration of dual antiplatelet therapy (DAPT) – Signa Vitae

The following gives you a quick look at many typical cardiac medications. Your prescription may have a different name from the ones listed on this chart. Brand names commonly available in the U. For your information and reference, we have included generic names as well as major trade names to help you identify what you may be taking; however, the AHA is not recommending or endorsing any specific products.

If your prescription medication isn't on this list, remember that your healthcare provider and pharmacist are your best sources of information. It's important to discuss all of the drugs you take with your doctor and understand their desired effects and possible side effects. Never stop taking a medication and never change your dose or frequency without first consulting your doctor.

Decreases the clotting coagulating ability of the blood. Sometimes called blood thinners, although they do not actually thin the blood. They do NOT dissolve existing blood clots. Used to treat certain blood vessel, heart and lung conditions. Patients who have had heart attacks, patients who are treated with stents in their coronary arteries, and some patients who undergo coronary artery bypass graft surgery CABG are treated at the same time with two types of antiplatelet agents to prevent blood clotting.

This is called dual antiplatelet therapy DAPT. One antiplatelet agent is aspirin. Almost everyone with coronary artery disease, including those who have had a heart attack, stent, or CABG are treated with aspirin for the rest of their lives. A second type of antiplatelet agent, called a P2Y 12 inhibitor, is usually prescribed for months or years in addition to the aspirin therapy.

The type of medication and the duration of your treatment will vary based on a discussion with your healthcare provider weighing the risks of potential bleeding complications. These are general recommendations for the duration and type of dual anti-platelet therapy which should be used after coronary artery stenting, heart attack and CABG. Again, it is important to talk to your doctor about your specific treatment plan. Expands blood vessels and decreases resistance by lowering levels of angiotensin II. Allows blood to flow more easily and makes the heart's work easier or more efficient.

Rather than lowering levels of angiotensin II as ACE inhibitors do angiotensin II receptor blockers prevent this chemical from having any effects on the heart and blood vessels.